Ligand Pharmaceuticals (NASDAQ: LGND ) shares moved up 13.98% to $19.00 at 10:40 am. The volume of Ligand Pharmaceuticals shares traded was 1663% higher than normal. Ligand Pharmaceuticals partner GlaxoSmithKline (NYSE: GSK ) announced today that the U.S. Food and Drug Administration (FDA) has approved new indication for